Impending Bill Seeks to Increase H1-B Visa Cap as Biotech Applicants Continue Growing | GenomeWeb

Biotechnology industry leaders nationwide will be closely monitoring the progress of an immigration bill that is set to begin deliberations in the US Senate this week because it will affect their ability to hire professionals from overseas.
The bill, which would raise to 115,000 from 65,000 the number of individuals eligible for H1-B visas during a US fiscal year, is particularly important in California, where biotech companies rely more on foreign-born workers than any other state.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.